Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: A follow-up study in Sweden

Rheumatology

Volumn 49, Issue 6, 2010, Pages 1158-1163

  Ji, Jianguang ^a   Liu, Xiangdong ^a   Sundquist, Kristina ^b   Sundquist, Jan ^a,c   Hemminki, Kari ^a,d  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cancer; Giant cell arteritis; National databases; Polymyalgia rheumatica

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; ENDOCRINE TUMOR; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HOSPITALIZATION; HUMAN; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MYELOMA; NERVOUS SYSTEM TUMOR; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; RHEUMATIC POLYMYALGIA; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; SWEDEN;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GIANT CELL ARTERITIS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POLYMYALGIA RHEUMATICA; RISK FACTORS; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 77953504751     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq040     Document Type: Article

References (21)

1. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008;372:234-45.
2. Dwolatzky T, Sonnenblick M, Nesher G. Giant cell arteritis and polymyalgia rheumatica: clues to early diagnosis. Geriatrics 1997;52:38-40, 43-4.
3. Cimmino MA, Zaccaria A. Epidemiology of polymyalgia rheumatica. Clin Exp Rheumatol 2000;18:S9-11.
4. Weyand CM, Ma-Krupa W, Goronzy JJ. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev 2004;3:46-53.
5. Bartolome MJ, Martinez-Taboda VM, Lopez-Hoyos M, Blanco R, Rodriguez-Valverde V. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis. Clin Exp Rheumatol 2001; 19:259-64.
6. Hemminki K, Li X, Sundquist K, Sundquist J. Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology 2008;47:698-701.
7. Ji J, Shu X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden. Br J Cancer 2009;100:1499-502.
8. Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalised asthma patients. Br J Cancer 2009;100:829-33.
9. Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT. No increased frequency of malignant neoplasms in poly-myalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol 2002;29:2143-7.
10. Mertens JC, Willemsen G, Van Saase JL, Bolk JH, Dijkmans BA. Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients. Clin Rheumatol 1995;14:650-5.
11. Haga HJ, Eide GE, Brun J, Johansen A, Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1993;20:1335-9.
12. Schaufelberger C, Bengtsson BA, Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol 1995;34:261-4.
13. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Lyon: IARC, 1994.
14. Hemminki K, Ji J, Brandt A, Mousavi SM, Sundquist J. The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. Int J Cancer. Advance Access published July 29, 2009, doi: 10.1002/ijc.24795.
15. Hemminki K, Forsti A, Ji J. Incidence and familial risks in pituitary adenoma and associated tumors. Endocr Relat Cancer 2007;14:103-9.
16. Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, South Norway: a prospective study 1987-94. J Rheumatol 1997;24:1739-43.
17. Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden. Ann Oncol 2009;20:1121-6.
18. Hemminki K, Li X, Sundquist J, Sundquist K. Cancer risks in ulcerative colitis patients. Int J Cancer 2008;123: 1417-21.
19. Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 2009; 100:822-8.
20. Kane I, Menon S. Carcinoma of the prostate presenting as polymyalgia rheumatica. Rheumatology 2003;42: 385-7.
21. Ahmed SA, Hissong BD, Verthelyi D, Donner K, Becker K, Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect 1999;107(Suppl. 5): 681-6.